Tags : Advanced or Metastatic Cancers

Bristol-Myers (BMS) Collaborates with Vedanta Biosciences to Develop Combination Therapy

Vartika Singh December 11, 2018

Shots: BMS to make equity investment in Vedanta and Vedanta will evaluate Opdivo + VE800, for advanced or metastatic cancers The focus of the collaboration is to develop combination therapy […]readmore

Tags : Advanced or Metastatic Cancers

Bristol-Myers (BMS) Collaborates with Vedanta Biosciences to Develop Combination Therapy

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Advanced or Metastatic Cancers

Bristol-Myers (BMS) Collaborates with Vedanta Biosciences to Develop Combination Therapy

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company